An integrated robotic system for high‐throughput process development of cell and virus culture conditions: Application to biosafety level 2 live virus vaccines
- 31 August 2015
- journal article
- technical report
- Published by Wiley in Engineering in Life Sciences
- Vol. 16 (2) , 202-209
Abstract
Live virus vaccines are a critical component of worldwide vaccination strategy for reducing disease burden but often require complex biological production processes that are sensitive to many different factors, both known and often unknown. Prior application of high‐throughput process development (HTPD) approaches to these processes has been hampered by a complex design space, low‐throughput analytics, and challenges inherent in biosafety level 2 containment and asepsis in laboratory automation. In 2013, we initiated a project with HighRes Biosolutions to design and install an integrated high‐throughput screening platform to enable HTPD for biosafety level 2 upstream process development studies. The system incorporates the necessary tools for performing cell and virus culture studies in microplates, as well as advanced analytical capabilities necessary for assessment of cell phenotype, product quality, and antigen yield. To date, we have applied this system to screen optimal media formulations and viral production conditions in support of two viral vaccine programs, with phenotypic assays performed as an integrated part of the workflow. This case study illustrates the power of HTPD in addressing large‐scale biological screening challenges by narrowing a vast design space and identifying parameter interactions in live virus production processes.Keywords
This publication has 26 references indexed in Scilit:
- Fetal bovine serum inhibits hepatitis C virus attachment to host cellsJournal of Virological Methods, 2013
- A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virusVirology Journal, 2013
- High-throughput process development for biopharmaceutical drug substancesTrends in Biotechnology, 2011
- A review of advanced small‐scale parallel bioreactor technology for accelerated process development: Current state and future needBiotechnology Progress, 2010
- A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus SensitizersMolecular Therapy, 2010
- Optimization of chemically defined cell culture media – Replacing fetal bovine serum in mammalian in vitro methodsToxicology in Vitro, 2010
- Advances in clone selection using high‐throughput bioreactorsBiotechnology Progress, 2010
- High-Throughput Screening at Biosafety Level 2 with High Flexibility: MicroStar BSL2SLAS Technology, 2009
- The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidatesNature Reviews Drug Discovery, 2007
- Fetal calf serum inhibits virus genome expression in Madin-Darby canine kidney cells persistently infected with influenza A virusMedical Microbiology and Immunology, 2007